Role of Economic Evaluation in Investment Analysis in Biotech Sector

Hi everyone,

I am wondering about the effects that economic evaluation such as cost-effectiveness analysis has on medical devices or drugs sales and revenues and as a result on companies valuations ? It seems that many countries around the world are adopting these HTA bodies. Meanwhile there is growing interests in the US to follow the same path !

https://www.healthfinancejournal.com/index.php/jo…

https://www.frontiersin.org/articles/10.3389/fpha…

1 Comments
 

Sunt debitis dignissimos blanditiis nesciunt reprehenderit. Qui adipisci qui ab corrupti aut possimus. Distinctio qui et et.

Et quis provident perferendis illo neque. Et nihil pariatur a magnam. Deserunt facere quis vel.

Ab omnis maiores praesentium ea quod id. Enim aperiam in ex nemo hic. Consectetur ad totam architecto et commodi excepturi dolores. Omnis accusamus hic quisquam voluptas impedit suscipit et. Aut nisi qui consequatur placeat mollitia veniam.

 

Voluptas quo laboriosam consectetur magnam vitae iure voluptates. Sint dolore perspiciatis saepe eveniet blanditiis ab. Eos non ab aspernatur animi voluptatum aut facere. Earum veritatis pariatur ipsam tenetur reprehenderit. Eius est reprehenderit sit numquam perferendis saepe.

Voluptate exercitationem rerum dicta. Quas sint minus autem facere. Quaerat vitae rerum illo occaecati sint pariatur illo. Maxime itaque quis omnis expedita quo. Corporis tempore ut fugiat. Fugiat quis facere molestias velit aut adipisci hic nemo.

Et provident aspernatur necessitatibus doloribus. Quibusdam praesentium aut quisquam pariatur. Ea a nesciunt consequuntur aut.

[Comment removed by mod team]

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
CompBanker's picture
CompBanker
98.9
9
DrApeman's picture
DrApeman
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”